other names
  • AVIDITY PARTNERS MANAGEMENT LP

Adviser Profile

Exempt Reporting Adviser

2B(3)- PF>150mn act solely as an adviser to private funds but you are no longer eligible to check box 2.B.(2) because you have assets under management, as defined in rule 203(m)-1, in the United States of $150 million or more

Private Fund GAV* 0
SMA’s No
Private Funds 0 1

Private Funds

Employees

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker252828108 Stock NameDIANTHUS THERAPEUTICS INC $ Position$184,747,355 % Position42.00% $ Change113.00% # Change0.00%
Stck Ticker687604108 Stock NameORUKA THERAPEUTICS INC $ Position$52,020,606 % Position12.00% $ Change160.00% # Change15.00%
Stck Ticker008064206 Stock NameJADE BIOSCIENCES INC $ Position$34,177,275 % Position8.00% $ Change58.00% # Change0.00%
Stck Ticker46489V302 Stock NamePERSPECTIVE THERAPEUTICS INC $ Position$23,594,996 % Position5.00% $ Change167.00% # Change88.00%
Stck Ticker29337E102 Stock NameENLIVEN THERAPEUTICS INC $ Position$16,492,000 % Position4.00% $ Change663.00% # Change185.00%
Stck Ticker21077P108 Stock NameCONTEXT THERAPEUTICS INC $ Position$11,795,910 % Position3.00% $ Change46.00% # Change-9.00%
Stck Ticker01021M104 Stock NameAKTIS ONCOLOGY INC $ Position$8,785,613 % Position2.00% $ Change # Change
Stck Ticker697947109 Stock NamePALVELLA THERAPEUTICS INC NE $ Position$8,982,400 % Position2.00% $ Change345.00% # Change263.00%
Stck Ticker759916109 Stock NameREPLIGEN CORP $ Position$9,204,518 % Position2.00% $ Change12.00% # Change55.00%
Stck TickerG5960L103 Stock NameMEDTRONIC PLC $ Position$8,097,000 % Position2.00% $ Change-22.00% # Change-7.00%